The magnitude and concentration of selling—especially by the CEO—suggests caution ahead of upcoming catalysts or earnings. Monitor for further divestitures or news that may confirm weakening confidence in near-term prospects.
Price Chart
Executive Summary
BridgeBio Pharma CEO Kumar Neil sold shares worth over $1.6 million in open-market transactions, while Director Hannah Valantine exercised options and sold 8,671 shares for $624,312. The cluster is dominated by significant insider selling, with total open-market dispositions amounting to $2.27 million over seven days.
Key Financial Metrics
Key Facts
- CEO Kumar Neil sold 24,027 shares in two transactions totaling $1.64 million at prices between $68.36 and $68.48.
- Director Hannah Valantine exercised 8,671 options (intrinsic value $237,238.56) and sold all shares at $72 for $624,312 in proceeds.
- Total open-market sales in the cluster: $2.27 million.
- No open-market purchases or grants reported in the 7-day window.
- Total insider sales over the past 30 days now amount to $2.4 million.
Financial Impact
$2.27 million in net open-market selling by insiders over 7 days, representing 0.017% of the company's $13.5B market cap
Risk Factors
- Perceived lack of confidence from top leadership could pressure sentiment.
- Potential for additional insider selling if near-term catalysts are delayed or underperform.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (5 trades, 7d window) | cluster-BBIO-1773698745039 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 4w ago | 8-K | $76.59 $65.97 | ▼ −13.87% | ▼ −13.68% | $67.47 (−11.90%) |
Aug 26, 2026 5w ago | Press Release | $79.37 $66.28 | ▼ −16.49% | ▼ −16.72% | $67.47 (−14.99%) |
Aug 22, 2026 5w ago | Institutional Cluster | $81.07 $69.23 | ▼ −14.60% | ▼ −15.92% | $67.47 (−16.77%) |
Aug 17, 2026 6w ago | 8-K | $79.89 $72.38 | ▼ −9.40% | ▼ −7.87% | $67.47 (−15.54%) |
Aug 13, 2026 7w ago | Press Release | $79.86 $72.38 | ▲ +9.37% | ▲ +7.38% | $67.47 (+15.51%) |
Aug 10, 2026 7w ago | 8-K | $84.67 $76.08 | ▼ −10.15% | ▼ −9.09% | $67.47 (−20.31%) |
Aug 10, 2026 7w ago | Press Release | $84.67 $76.08 | ▼ −10.15% | ▼ −9.09% | $67.47 (−20.31%) |
Jul 13, 2026 11w ago | Insider Cluster | $83.08 $84.67 | ▲ +1.91% | ▼ −1.27% | $67.47 (−18.78%) |
Jun 28, 2026 13w ago | Press Release | $72.01 $84.02 | ▲ +16.68% | ▲ +16.96% | $67.47 (−6.30%) |
Jun 24, 2026 14w ago | 144 | $69.69 $82.93 | ▲ +19.00% | ▲ +18.47% | $67.47 (−3.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access